- Organoid Model in Idiopathic Pulmonary Fibrosis
-
Lee J, Kim JH, Hong SH, Yang SR
- KMID: 2513078
- Int J Stem Cells.
- 2021 Feb;14(1):1-8.
- doi: 10.15283/ijsc20093
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive- fibrosing disease characterized by extensive deposition of extracellular matrix (ECM), scarring of the lung parenchyma. Despite increased awareness of IPF, etiology and... -
- CITED
-
- Close
- SHARE
-
- Close
- Production of Functional Hepatobiliary Organoids from Human Pluripotent Stem Cells
-
Wu D, Chen X, Sheng Q, Chen W, Zhang Y, Wu F
- KMID: 2513089
- Int J Stem Cells.
- 2021 Feb;14(1):119-126.
- doi: 10.15283/ijsc20152
The research on human hepatobiliary development and disorders has been constrained by minimal access to human fetal tissue, and low accuracy of animal models. To overcome this problem, we have... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine
-
Lee H, Son MY
- KMID: 2513079
- Int J Stem Cells.
- 2021 Feb;14(1):9-20.
- doi: 10.15283/ijsc20140
Innovative advances in stem cell research have resulted in the development of organoids, which are widely used as in vitro models of human organ development and for disease. The long-term... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Gene Modification in Placenta-Derived Mesenchymal Stem Cells Based on Nonviral Electroporation
-
Kim JY, Choi JH, Kim SH, Park H, Lee D, Kim GJ
- KMID: 2513088
- Int J Stem Cells.
- 2021 Feb;14(1):112-118.
- doi: 10.15283/ijsc20117
Mesenchymal stem cell (MSC)-based therapy using gene delivery systems has been suggested for degenerative diseases. Although MSC-based clinical applications are effective and safe, the mode of action remains unclear. Researchers... -
- CITED
-
- Close
- SHARE
-
- Close
- Culturing at Low Cell Density Delays Cellular Senescence of Human Bone Marrow-Derived Mesenchymal Stem Cells in Long-Term Cultures
-
Kim SN, Choi B, Lee CJ, Moon JH, Kim MK, Chung E, Song SU
- KMID: 2513087
- Int J Stem Cells.
- 2021 Feb;14(1):103-111.
- doi: 10.15283/ijsc20078
Background and Objectives: Mesenchymal stem cells (MSCs) have immense therapeutic potential for treating intractable and immune diseases. They also have applications in regenerative medicine in which distinct treatments do not... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Human Bone Marrow-Derived Mesenchymal Stem Cell Conditioned Media Produced with Fetal Bovine Serum or Human Platelet Lysate on Skin Rejuvenation Characteristics
-
Kim SN, Lee CJ, Nam J, Choi B, Chung E, Song SU
- KMID: 2513086
- Int J Stem Cells.
- 2021 Feb;14(1):94-102.
- doi: 10.15283/ijsc20070
Background and Objectives: Human mesenchymal stem cell-conditioned medium (MSC-CM) is produced using mesenchymal stem cell culture technology and has various benefits for the skin, including wrinkle removal, skin regeneration, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous Bone-Marrow vs.Peripheral Blood Mononuclear Cells Therapy for Peripheral Artery Disease in Diabetic Patients
-
Yunir E, Kurniawan F, Rezaprasga E, Wijaya IP, Suroyo I, Matondang S, Irawan C, Soewondo P
- KMID: 2513080
- Int J Stem Cells.
- 2021 Feb;14(1):21-32.
- doi: 10.15283/ijsc20088
Diabetes mellitus (DM) remains one of the most important risk factors for peripheral artery disease (PAD), with approximately 20% of DM patients older than 40 years old are affected with... -
- CITED
-
- Close
- SHARE
-
- Close
- First Year Results of Suprachoroidal Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Degenerative Macular Diseases
-
Kahraman NS, Gonen ZB, Sevim DG, Oner A
- KMID: 2513082
- Int J Stem Cells.
- 2021 Feb;14(1):47-57.
- doi: 10.15283/ijsc20025
Background and Objectives: This study shows the clinical data of 1-year follow-up of 8 patients with degenerative macular diseases who received suprachoroidal adipose tissue derived mesenchymal stem cell (ADMSC) implantation. Methods... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Stem Cell-Derived Retinal Pigment Epithelial Cells as a Model for Drug Screening and Pre-Clinical Assays Compared to ARPE-19 Cell Line
-
Oliveira CR, Paiva MRBd, Ribeiro MCS, Andrade GF, Carvalho JL, Gomes DA, Nehemy M, Fialho SL, Silva-Cunha A, Góes AMd
- KMID: 2513084
- Int J Stem Cells.
- 2021 Feb;14(1):74-84.
- doi: 10.15283/ijsc20094
Background and Objectives: Eye diseases have a high socioeconomic impact on society and may be one of the fields in which most stem cell-related scientific accomplishments have been achieved recently.... -
- CITED
-
- Close
- SHARE
-
- Close
- Dysregulated Dermal Mesenchymal Stem Cell Proliferation and Differentiation Interfered by Glucose Metabolism in Psoriasis
-
Zhao X, Xing J, Li J, Hou R, Niu X, Liu R, Jiao J, Yang X, Li J, Liang J, Zhou L, Wang Q, Chang W, Yin G, Li X, Zhang K
- KMID: 2513085
- Int J Stem Cells.
- 2021 Feb;14(1):85-93.
- doi: 10.15283/ijsc20073
Background and Objectives: Psoriasis is a chronic inflammatory skin disease, which the mechanisms behind its initiation and development are related to many factors. DMSCs (dermal mesenchymal stem cells) represent an... -
- CITED
-
- Close
- SHARE
-
- Close
- TL1A/TNFR2 Axis Enhances Immunoregulatory Effects of Bone Marrow Derived Mesenchymal Stem Cell by Indian Hedgehog Signaling Pathway
-
Al-Azab M, Walana W, Wei J, Li W, Tang Y, Wei X, Almoiliqy M, Shopit A, Abbas EE, Adlat S, Awsh M, Li X, Wang B
- KMID: 2513083
- Int J Stem Cells.
- 2021 Feb;14(1):58-73.
- doi: 10.15283/ijsc19121
Background and Objectives: The immunomodulatory potential of mesenchymal stem cells (MSCs) can be regulated by a variety of molecules, especially cytokines. The inflammatory cytokine, TNF-like ligand 1A (TL1A), has been... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of L-Ascorbic Acid and Serum Reduction on Tenogenic Differentiation of Human Mesenchymal Stromal Cells
-
Bochon K, Zielniok K, Gawlak M, Zawada K, Zarychta-Wiśniewska W, Siennicka K, Struzik S, Pączek L, Burdzińska A
- KMID: 2513081
- Int J Stem Cells.
- 2021 Feb;14(1):33-46.
- doi: 10.15283/ijsc20023
Background and Objectives: Despite significant improvement in the treatment of tendon injuries, the full tissue recovery is often not possible because of its limited ability to auto-repair. The transplantation of... -
- CITED
-
- Close
- SHARE
-
- Close
